School of Electrical, Information and Communication Engineering, Kanazawa University, Kakumamachi, Kanazawa, Ishikawa, 920-1192, Japan.
Institute of Liberal Arts and Science, Kanazawa University, Kanazawa, Japan.
J Med Syst. 2024 Mar 8;48(1):30. doi: 10.1007/s10916-024-02040-8.
Although magnetic resonance imaging (MRI) data of patients with multiple myeloma (MM) are used to predict prognosis, few reports have applied artificial intelligence (AI) techniques for this purpose. We aimed to analyze whole-body diffusion-weighted MRI data using three-dimensional (3D) convolutional neural networks (CNNs) and Gradient-weighted Class Activation Mapping (Grad-CAM), an explainable AI, to predict prognosis and explore the factors involved in prediction. We retrospectively analyzed the MRI data of a total of 142 patients with MM obtained from two medical centers. We defined the occurrence of progressive disease after MRI evaluation within 12 months as a poor prognosis and constructed a 3D CNN-based deep learning model to predict prognosis. Images from 111 cases were used as the training and internal validation data; images from 31 cases were used as the external validation data. Internal validation of the AI model with stratified 5-fold cross-validation resulted in a significant difference in progression-free survival (PFS) between good and poor prognostic cases (2-year PFS, 91.2% versus [vs.] 61.1%, P = 0.0002). The AI model clearly stratified good and poor prognostic cases in the external validation cohort (2-year PFS, 92.9% vs. 55.6%, P = 0.004), with an area under the receiver operating characteristic curve of 0.804. According to Grad-CAM, the MRI signals of the spleen and bones of the vertebrae and pelvis contributed to prognosis prediction. This study is the first to show that image analysis of whole-body MRI using a 3D CNN without any other clinical data is effective in predicting the prognosis of patients with MM.
尽管磁共振成像(MRI)数据可用于预测多发性骨髓瘤(MM)患者的预后,但很少有报道应用人工智能(AI)技术来实现这一目标。我们旨在使用三维(3D)卷积神经网络(CNN)和 Gradient-weighted Class Activation Mapping(Grad-CAM)——一种可解释的 AI,对全身弥散加权 MRI 数据进行分析,以预测预后并探索参与预测的因素。我们回顾性分析了来自两个医疗中心的 142 名 MM 患者的 MRI 数据。我们将 MRI 评估后 12 个月内疾病进展定义为预后不良,并构建了基于 3D CNN 的深度学习模型来预测预后。111 例图像用于训练和内部验证数据;31 例图像用于外部验证数据。采用分层 5 折交叉验证对 AI 模型进行内部验证,结果显示预后良好和不良病例之间的无进展生存期(PFS)存在显著差异(2 年 PFS,91.2% vs. [vs.] 61.1%,P = 0.0002)。AI 模型在外部验证队列中清楚地区分了预后良好和不良的病例(2 年 PFS,92.9% vs. 55.6%,P = 0.004),其受试者工作特征曲线下面积为 0.804。根据 Grad-CAM,脾脏和脊柱及骨盆骨骼的 MRI 信号有助于预后预测。本研究首次表明,无需任何其他临床数据,使用 3D CNN 对全身 MRI 进行图像分析可有效预测 MM 患者的预后。